MDMark J. Delorey

Mark J. Delorey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mark J. Delorey has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sustained dengue transmission and seroprevalence in the U.S. Virgin Islands

    by Valerie V. Mac, Joshua M. Wong, Emma S. Jones, Brad J. Biggerstaff, Mark Delorey, Matt D.T. Hitchings, Zachary J. Madewell, Janice Perez-Padilla, Hannah R. Volkman, Freddy A. Medina, et al.

    Objective: To estimate dengue virus (DENV) seroprevalence and assess parental vaccine perceptions among children in the US Virgin Islands (USVI). Methods: A cross-sectional serosurvey was conducted during April–May 2022 among 372 children aged 8–16 years from 15 schools across USVI. Past DENV infection was determined using a dengue IgG rapid diagnostic test. Data on demographics, dengue knowledge, and vaccine acceptance were collected from parents. Catalytic models estimated annual DENV force of infection (FOI) using seroprevalence and case data from 2010–2022. Results: Seroprevalence among children aged 8–13 years was 47% (95% CI: 29%, 68%). FOI peaked during 2012–2013 outbreaks and remained low in other years. Only 17% of parents were aware of an approved dengue vaccine, and 25% reported they would vaccinate their child. Conclusions: Nearly half of children had prior DENV infection. Despite this risk, parental awareness of dengue vaccination was low, underscoring gaps in detection, diagnosis, and preparedness for vaccine implementation. Policy Implications: These data highlight the need for enhanced surveillance, public education, and targeted planning for dengue vaccine introduction in endemic US jurisdictions.


  • Open Access

    Reconstructing dengue transmission and assessing future outbreak risk in America Samoa, 2008–2023

    by Sandra J. Kiplagat, Forrest K. Jones, Matt D.T. Hitchings, Scott Anesi, Angelynn Papu, Hans Desale, Janice Perez-Padilla, Emma S. Jones, Mark Delorey, Laura E. Adams, et al.

    American Samoa experienced multiple dengue outbreaks during 2008–2023. We employed a catalytic model to reconstruct historical dengue virus (DENV) transmission dynamics by estimating the annual force of infection (FOI) – or probability of DENV infection among susceptible individuals – during this period. We incorporated data from 661 dengue cases between 2016–2023 and two serosurveys. We also modeled the proportion of the population with 0, 1, or ≥2 previous infections to assess population risk. We estimated elevated FOIs during 2009 (11%; 95% CrI: 2%–38%), 2010 (15%; 95% CrI: 5%–29%), 2017 (50%; 95% CrI: 37%–67%), and 2018 (13%; 95% CrI 7%–24%). The proportion of the population with 0 previous infections was 22% in 2016, declined to 11% following the 2017–2018 outbreak, and rebounded to 20% in 2023. Our findings indicate a pattern of episodic dengue transmission in American Samoa, with substantial fluctuations in population immunity over time.

  • Open Access

    Utility of sentinel surveillance as an early warning system for emerging pathogens in a low-resource setting: correlations of dengue, chikungunya, Zika, and COVID-19 trends between sentinel and passive surveillance systems in Puerto Rico, 2012–2023

    by Alfonso C. Hernandez-Romieu, Zachary J. Madewell, Mark Delorey, Hannah R. Volkman, Liliana Sanchez-Gonzalez, Vanessa Rivera-Amill, Diego Sainz, Jorge Bertrán-Pasarell, Verónica M. Frasqueri-Quintana, Jomil Torres Aponte, et al.

    The representativeness and timeliness of sentinel surveillance for endemic and emerging arboviral and respiratory diseases in low-resource settings are understudied. We compared laboratory-confirmed epidemic dengue, non-epidemic dengue, Zika, chikungunya, and COVID-19 (pre-Omicron and Omicron periods) cases reported in Puerto Rico’s Sentinel Enhanced Dengue Surveillance System (SEDSS) with island-wide trends reported by the Department of Health’s passive disease surveillance system (PADSS). We plotted trends over time to assess representativeness and used lagged cross-correlations to determine whether SEDSS reporting preceded PADSS. SEDSS trends were representative of island-wide trends for all pathogens. SEDSS preceded reporting in PADSS by up to three, eight, and two weeks for epidemic dengue, Zika, and pre-Omicron COVID-19, respectively. Increasing case trends for non- epidemic dengue and chikungunya occurred simultaneously in both systems. In Puerto Rico, sentinel surveillance was representative of island-wide trends and could provide early warning for dengue epidemics and emerging diseases, such as Zika, and COVID-19.


  • Open Access

    Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico

    by Dania M. Rodriguez, Chelsea G. Major, Liliana Sánchez-González, Emma Jones, Mark J. Delorey, Claudia Alonso, Vanessa Rivera-Amill, Gabriela Paz-Bailey, Laura E. Adams


  • Acceptability of a Chikungunya Virus Vaccine, United States Virgin Islands

    by Emily J. Curren, Esther M. Ellis, Morgan J. Hennessey, Mark J. Delorey, Marc Fischer, J. Erin Staples

    Chikungunya virus, a mosquito-borne alphavirus, causes acute febrile illness with polyarthralgia. Groups at risk for severe disease include neonates, people with underlying medical conditions, and those aged ≥ 65 years. Several chikungunya vaccines are in late clinical development with licensure expected in the United States during 2023. We administered a questionnaire to randomly selected households in the U.S. Virgin Islands (USVI) to assess interest in a hypothetical chikungunya vaccine. Estimates were calibrated to age and sex of USVI population, and univariate and multivariable analyses were performed. Of 966 participants, 520 (adjusted 56%, 95% CI = 51–60%) were interested in receiving the vaccine. Of 446 participants not interested in vaccination, 203 (adjusted 47%, 95% CI = 41–52%) cited safety concerns as the reason. Educational efforts addressing vaccine safety concerns and risk factors for severe disease would likely improve vaccine acceptability and uptake among those most at risk.


  • Open Access

    Dengue Vaccine Acceptability Before and after the Availability of COVID-19 Vaccines in Puerto Rico

    by Dania M. Rodriguez, Chelsea G. Major, Liliana M. Sánchez-González, Emma Jones, Mark Delorey, Claudia Alonso, Vanessa Rivera-Amill, Gabriela Paz-Bailey, Laura E. Adams

    Dengue is a growing public health threat, causing approximately 400 million infections annually. In June 2021, the Advisory Committee on Immunization Practices recommended the first dengue vaccine (CYD-TDV) for children aged 9–16 years with a previous dengue infection, living in endemic areas, such as Puerto Rico (PR). As the COVID-19 pandemic affected vaccine intention worldwide, we assessed dengue vaccine intention before (pre-COVID) and after (post-COVID) COVID-19 vaccine availability among participants enrolled in the Communities Organized to Prevent Arboviruses (COPA) cohort to prepare for dengue vaccine implementation in PR. We used logistic regression models to evaluate changes in dengue vaccine intention by interview timing and participant characteristics. Among 2,513 participants pre-COVID, 2,512 answered the dengue vaccine intention question for themselves, and 1,564 answered relative to their children. Post-COVID, dengue vaccine intention in adults increased for themselves from 73.4% to 84.5% (adjusted odds ratio (aOR)=2.27, 95%CI=1.90–2.71) and relative to their children from 75.6% to 85.5% (aOR=2.21, 95%CI=1.75–2.78). Among all participants, groups with higher dengue vaccine intention included those who reported previous year influenza vaccine uptake and those who reported being frequently bitten by mosquitos, compared to those who did not. Adult males were also more likely to intend to vaccinate themselves than females. Respondents who were employed or in school were less likely to intend to vaccinate compared to those who were not working. The primary reasons for vaccine hesitancy were concerns with side effects and not believing in vaccines, which should be considered during educational strategies prior to dengue vaccine implementation. In general, dengue vaccine intention is high in PR and has increased after COVID-19 vaccine availability, potentially due to increased awareness of vaccine importance during the COVID-19 pandemic.

  • Open Access

    An Acarological Risk Model Predicting the Density and Distribution of Host-Seeking Ixodes scapularis Nymphs in Minnesota

    by Tammi L. Johnson, Karen A. Boegler, Rebecca J. Clark, Mark J. Delorey, Jenna K. H. Bjork, Frances M. Dorr, Elizabeth K. Schiffman, David F. Neitzel, Andrew J. Monaghan, Rebecca J. Eisen

    Ixodes scapularis is the vector of at least seven human pathogens in Minnesota, two of which are known to cause Lyme disease (Borrelia burgdorferi sensu stricto and Borrelia mayonii). In Minnesota, the statewide incidence of Lyme disease and other I. scapularis–borne diseases and the geographic extent over which cases have been reported have both increased substantially over the last two decades. These changes correspond with an expanding distribution of I. scapularis over a similar time frame. Because the risk of exposure to I. scapularis–borne pathogens is likely related to the number of ticks encountered, we developed an acarological risk model predicting the density of host-seeking I. scapularis nymphs (DON) in Minnesota. The model was informed by sampling 81 sites located in 42 counties in Minnesota. Two main foci were predicted by the model to support elevated densities of host-seeking I. scapularis nymphs, which included the seven-county Minneapolis-St. Paul metropolitan area and counties in northern Minnesota, including Lake of the Woods and Koochiching counties. There was substantial heterogeneity observed in predicted DON across the state at the county scale; however, counties classified as high risk for I. scapularis–borne diseases and counties with known established populations of I. scapularis had the highest proportion of the county predicted as suitable for host-seeking nymphs (≥ 0.13 nymphs/100 m2). The model provides insight into areas of potential I. scapularis population expansion and identifies focal areas of predicted suitable habitat within counties where the incidence of I. scapularis–borne diseases has been historically low.


  • Open Access

    Host-Seeking Phenology ofIxodes pacificus(Acari: Ixodidae) Nymphs in Northwestern California in Relation to Calendar Week, Woodland Type, and Weather Conditions

    by Rebecca J. Eisen, Rebecca J. Clark, Andrew J. Monaghan, Lars Eisen, Mark J. Delorey, Charles B. Beard

    Local knowledge of when humans are at elevated risk for exposure to tick vectors of human disease agents is required both for the effective use of personal protection measures to avoid tick bites and for implementation of control measures to suppress host-seeking ticks. Here, we used previously published data on the seasonal density of host-seeking Ixodes pacificus Cooley and Kohls nymphs, the primary vectors of Lyme disease spirochetes in the far western USA, collected across a broad habitat and climate gradient in northwestern California to identify predictors of periods of time within the year when questing nymphal density is elevated. Models based on calendar week alone performed similarly to models based on calendar week and woodland type, or meteorological variables. The most suitable model for a given application will depend on user objectives, timescale of interest, and the geographic extent of predictions. Our models sought not only to identify when seasonal host-seeking activity commences, but also when it diminishes to low levels. Overall, we report a roughly 5–7 month period in Mendocino County during which host-seeking nymphal densities exceed a low threshold value.


  • Open Access

    Transmission of Heartland Virus (Bunyaviridae:Phlebovirus) by Experimentally InfectedAmblyomma americanum(Acari: Ixodidae)

    by Marvin S. Godsey, Harry M. Savage, Kristen L. Burkhalter, Angela M. Bosco-Lauth, Mark J. Delorey

    Heartland virus (HRTV; Bunyaviridae: Phlebovirus ) is a recently described cause of human illness in the United States. After field studies conducted in 2012 implicated Amblyomma americanum (L.) as a vector of HRTV, we initiated experiments to assess the vector competence of A. americanum . Larval and nymphal ticks were immersed in high-titered suspensions of HRTV, and then tested for virus at various intervals postimmersion. In a later trial larval ticks were immersed in HRTV, followed by engorgement on a rabbit. A subset of postmolt nymphs was tested for HRTV to document transstadial transmission. Putatively infected nymphs were cofed with uninfected colony larvae to assess nonviremic transmission. In another trial, nymphs were fed on a rabbit and allowed to molt to the adult stage. Male and female ticks fed and mated upon a rabbit, and females were allowed to oviposit. Male and spent female ticks were tested for HRTV, and offspring of infected females were tested to assess vertical transmission. Infection rates of ≤50% were observed in immersed larvae and nymphs tested at intervals following immersion. Transstadial transmission from larvae to nymphs and then to adults was documented. HRTV was detected in a pool of nymphs molted from uninfected larvae cofed with infected nymphs. Vertical transmission of HRTV was observed in progeny of infected females. Infected females took longer to oviposit and produced fewer offspring. Serologic conversions (without viremia) in rabbits fed upon by immersed larvae or transstadially infected ticks indicate horizontal transmission of HRTV.


  • Open Access

    Potential for Co-Infection of a Mosquito-Specific Flavivirus, Nhumirim Virus, to Block West Nile Virus Transmission in Mosquitoes

    by Silvina Goenaga, Joan L. Kenney, Nisha K. Duggal, Mark Delorey, Gregory D. Ebel, Bo Zhang, Silvana C. Levis, Delia A. Enria, Aaron C. Brault

    Nhumirim virus (NHUV) is an insect-specific virus that phylogenetically affiliates with dual-host mosquito-borne flaviviruses. Previous in vitro co-infection experiments demonstrated prior or concurrent infection of Aedes albopictus C6/36 mosquito cells with NHUV resulted in a 10,000-fold reduction in viral production of West Nile virus (WNV). This interference between WNV and NHUV was observed herein in an additional Ae. albopictus mosquito cell line, C7-10. A WNV 2K peptide (V9M) mutant capable of superinfection with a pre-established WNV infection demonstrated a comparable level of interference from NHUV as the parental WNV strain in C6/36 and C7-10 cells. Culex quinquefasciatus and Culex pipiens mosquitoes intrathoracically inoculated with NHUVandWNV, or solely withWNVas a control, were allowed to extrinsically incubate the viruses up to nine and 14 days, respectively, and transmissibility and replication of WNV was determined. The proportion of Cx. quinquefasciatus mosquitoes capable of transmitting WNV was significantly lower for the WNV/NHUV group than the WNV control at seven and nine days post inoculation (dpi), while no differences were observed in the Cx. pipiens inoculation group. By dpi nine, a 40% reduction in transmissibility in mosquitoes from the dual inoculation group was observed compared to the WNV-only control. These data indicate the potential that infection of some Culex spp. vectors with NHUV could serve as a barrier for efficient transmissibility of flaviviruses associated with human disease.